Shares of Bovie Medical Co. (NYSE:BVX) traded up 5.2% during mid-day trading on Monday . The company traded as high as $3.38 and last traded at $3.01, with a volume of 190,477 shares changing hands. The stock had previously closed at $2.86.

A number of analysts have issued reports on the company. Zacks Investment Research raised Bovie Medical from a “sell” rating to a “hold” rating in a research report on Tuesday, July 19th. JMP Securities reissued an “outperform” rating and issued a $5.00 target price on shares of Bovie Medical in a research report on Wednesday, August 3rd.

The firm has a 50 day moving average price of $1.95 and a 200-day moving average price of $1.86. The company’s market cap is $82.24 million.

Bovie Medical (NYSE:BVX) last released its earnings results on Wednesday, May 11th. The medical device company reported ($0.07) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by $0.02. The company had revenue of $7.80 million for the quarter, compared to analysts’ expectations of $7.17 million. On average, equities research analysts forecast that Bovie Medical Co. will post ($0.13) EPS for the current fiscal year.

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.